Q2 2018

Source filing unavailable

Q2 2018 · —

Revenue

$5.16B

+2.1% vs Q2 2017

Net Income

$350.00M

−26.6% vs Q2 2017

EPS Diluted

$0.27

−28.9% vs Q2 2017

Gross Profit$4,143,000,000+1.0%

Operating Income$763,000,000−17.5%

Margins · derived

Gross margin

Same quarter

Metric	Q2 2018	Q2 2017	Q2 2016
Revenue	$5.16B	$5.05B	$5.47B
Net Income	$350.00M	$477.00M	—
EPS Diluted	$0.27	$0.38	—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

AstraZeneca PLC · CIK 901832 · Engraved from SEC EDGAR